93 related articles for article (PubMed ID: 27733338)
1. Construction of CTCF degradation cell line by CRISPR/Cas9 mediated genome editing.
Xie DJ; Shi ML; Zhang Y; Wang TY; Shen WL; Ye BY; Li P; He C; Zhang XY; Zhao ZH
Yi Chuan; 2016 Jul; 38(7):651-657. PubMed ID: 27733338
[TBL] [Abstract][Full Text] [Related]
2. CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.
Bailey CG; Metierre C; Feng Y; Baidya K; Filippova GN; Loukinov DI; Lobanenkov VV; Semaan C; Rasko JE
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513694
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation-independent removable insulator controls chromatin remodeling at the HOXA locus via retinoic acid signaling.
Ishihara K; Nakamoto M; Nakao M
Hum Mol Genet; 2016 Dec; 25(24):5383-5394. PubMed ID: 27798106
[TBL] [Abstract][Full Text] [Related]
4. CTCF Binding Polarity Determines Chromatin Looping.
de Wit E; Vos ES; Holwerda SJ; Valdes-Quezada C; Verstegen MJ; Teunissen H; Splinter E; Wijchers PJ; Krijger PH; de Laat W
Mol Cell; 2015 Nov; 60(4):676-84. PubMed ID: 26527277
[TBL] [Abstract][Full Text] [Related]
5. The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
[TBL] [Abstract][Full Text] [Related]
6. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice.
Lee HK; Willi M; Wang C; Yang CM; Smith HE; Liu C; Hennighausen L
Nucleic Acids Res; 2017 May; 45(8):4606-4618. PubMed ID: 28334928
[TBL] [Abstract][Full Text] [Related]
8. Epigenome editing strategies for the functional annotation of CTCF insulators.
Tarjan DR; Flavahan WA; Bernstein BE
Nat Commun; 2019 Sep; 10(1):4258. PubMed ID: 31534142
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 System.
Wang L; Yang L; Guo Y; Du W; Yin Y; Zhang T; Lu H
PLoS One; 2017; 12(1):e0169768. PubMed ID: 28068387
[TBL] [Abstract][Full Text] [Related]
10. Highly Efficient Genome Editing via CRISPR/Cas9 to Create Clock Gene Knockout Cells.
Korge S; Grudziecki A; Kramer A
J Biol Rhythms; 2015 Oct; 30(5):389-95. PubMed ID: 26243628
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
12. CTCF as a multifunctional protein in genome regulation and gene expression.
Kim S; Yu NK; Kaang BK
Exp Mol Med; 2015 Jun; 47(6):e166. PubMed ID: 26045254
[TBL] [Abstract][Full Text] [Related]
13. Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering.
Nuñez JK; Harrington LB; Doudna JA
ACS Chem Biol; 2016 Mar; 11(3):681-8. PubMed ID: 26857072
[TBL] [Abstract][Full Text] [Related]
14. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
15. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
[TBL] [Abstract][Full Text] [Related]
16. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.
Yi L; Li J
Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687
[TBL] [Abstract][Full Text] [Related]
19. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.
Zhou Y; Liu Y; Hussmann D; Brøgger P; Al-Saaidi RA; Tan S; Lin L; Petersen TS; Zhou GQ; Bross P; Aagaard L; Klein T; Rønn SG; Pedersen HD; Bolund L; Nielsen AL; Sørensen CB; Luo Y
Cell Mol Life Sci; 2016 Jul; 73(13):2543-63. PubMed ID: 26755436
[TBL] [Abstract][Full Text] [Related]
20. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
